Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis

被引:70
作者
Gryadunov, D
Mikhailovich, V
Lapa, S
Roudinskii, N
Donnikov, M
Pan'kov, S
Markova, O
Kuz'min, A
Chernousova, L
Skotnikova, O
Moroz, A
Zasedatelev, A
Mirzabekov, A
机构
[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia
[2] Russian Acad Med Sci, Cent TB Res Inst, Moscow, Russia
[3] Moscow Govt, Moscow AntiTB Ctr, Moscow, Russia
基金
俄罗斯基础研究基金会;
关键词
biochips; hybridisation; multidrug resistance; Mycobacterium tuberculosis; oligonucleotide microarrays; PCR;
D O I
10.1111/j.1469-0691.2005.01183.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A molecular approach was developed to identify drug-resistant strains of Mycobacterium tuberculosis by means of biochips with oligonucleotides immobilised in polyacrylamide gel pads. The technique was based on multiplex PCR, followed by hybridisation on an oligonucleotide microarray, and detected >95% of rifampicin-resistant and c. 80% of isoniazid-resistant M. tuberculosis isolates within 12 h. In total, 220 drug-resistant isolates and 131 clinical samples were tested using biochips. The sensitivity and specificity of the developed method were comparable with those of standard bacteriological testing of M. tuberculosis drug resistance.
引用
收藏
页码:531 / 539
页数:9
相关论文
共 31 条
[1]  
[Anonymous], CLIN MICROBIOL INFEC
[2]   The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis - Results of a multicenter prospective trial [J].
Catanzaro, A ;
Perry, S ;
Clarridge, JE ;
Dunbar, S ;
Goodnight-White, S ;
LoBue, PA ;
Peter, C ;
Pfyffer, GE ;
Sierra, MF ;
Weber, R ;
Woods, G ;
Mathews, G ;
Jonas, V ;
Smith, K ;
Della-Latta, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (05) :639-645
[3]   In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations [J].
Cavusoglu, C ;
Karaca-Derici, Y ;
Bilgic, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) :662-665
[4]   A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis [J].
Drobniewski, FA ;
Watterson, SA ;
Wilson, SM ;
Harris, GS .
JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (03) :271-278
[5]   New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis [J].
Garcia de Viedma, D ;
Infantes, MDD ;
Lasala, F ;
Chaves, F ;
Alcalá, L ;
Bouza, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :988-995
[6]   Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis [J].
Heep, M ;
Rieger, U ;
Beck, D ;
Lehn, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1075-1077
[7]   The need for global action against multidrug-resistant tuberculosis [J].
Heymann, SJ ;
Brewer, TF ;
Wilson, ME ;
Fineberg, HV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (22) :2138-2140
[8]   Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis [J].
Kelley, CL ;
Rouse, DA ;
Morris, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2057-2058
[9]  
Kent P.T., 1985, PUBLIC HLTH MYCOBACT
[10]   Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates [J].
Lee, ASG ;
Teo, ASM ;
Wong, SY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2157-2159